Efficacy and safety of antazoline vs propafenone for conversion of paroxysmal atrial fibrillation to sinus rhythm: a randomized, double-blind study (AnProAF).
Jarosław KarwowskiKarol WrzosekRenata Mączyńska-MazurukKatarzyna SzmarowskaJerzy RekoszAnna WiktorskaBeata MierzejewskaMateusz SoleckiMirosław DłużniewskiPublished in: Polish archives of internal medicine (2024)
Intravenous antazoline demonstrated efficacy and safety comparable to those of intravenous propafenone for acute conversion of nonvalvular paroxysmal AF to sinus rhythm in patients without heart failure.
Keyphrases
- atrial fibrillation
- heart failure
- catheter ablation
- oral anticoagulants
- left atrial
- left atrial appendage
- direct oral anticoagulants
- end stage renal disease
- ejection fraction
- chronic kidney disease
- percutaneous coronary intervention
- newly diagnosed
- high dose
- double blind
- peritoneal dialysis
- randomized controlled trial
- left ventricular
- low dose
- respiratory failure
- placebo controlled
- venous thromboembolism
- mechanical ventilation
- patient reported
- mitral valve